TY - JOUR
T1 - High prevalence of drug resistance amongst HIV-exposed and -infected children in a tuberculosis prevention trial
AU - Hesseling, Anneke C.
AU - Kim, S.
AU - Madhi, S.
AU - Nachman, S.
AU - Schaaf, H. S.
AU - Violari, A.
AU - Victor, T. C.
AU - McSherry, G.
AU - Mitchell, C.
AU - Cotton, M. F.
PY - 2012/2/1
Y1 - 2012/2/1
N2 - An emergence of drug-resistant tuberculosis (DR-TB) in settings affected by human immunodeficiency virus (HIV) and tuberculosis (TB) has been observed. We investigated the prevalence of DR-TB in P1041, a multicentred, randomised, double-blind trial which compared the administration of isoniazid (INH) to placebo, in HIV-exposed, non-infected and -infected African infants in the absence of any documented TB exposure. The prevalence of multidrug-resistant TB (MDR-TB) was 22.2% (95%CI 8.5-45.8) and INH monoresistance 5.6% (95%CI 0.1-27.6) among culture-confirmed cases, with all MDR-TB occurring in a single site. There was no association between INH treatment or placebo group, or between HIV infection status, and DR-TB prevalence. There was a high prevalence of DR-TB among HIV-exposed and -infected children. Surveillance of DR-TB among children in high-burden TB-HIV settings should be routine.
AB - An emergence of drug-resistant tuberculosis (DR-TB) in settings affected by human immunodeficiency virus (HIV) and tuberculosis (TB) has been observed. We investigated the prevalence of DR-TB in P1041, a multicentred, randomised, double-blind trial which compared the administration of isoniazid (INH) to placebo, in HIV-exposed, non-infected and -infected African infants in the absence of any documented TB exposure. The prevalence of multidrug-resistant TB (MDR-TB) was 22.2% (95%CI 8.5-45.8) and INH monoresistance 5.6% (95%CI 0.1-27.6) among culture-confirmed cases, with all MDR-TB occurring in a single site. There was no association between INH treatment or placebo group, or between HIV infection status, and DR-TB prevalence. There was a high prevalence of DR-TB among HIV-exposed and -infected children. Surveillance of DR-TB among children in high-burden TB-HIV settings should be routine.
UR - https://www.scopus.com/pages/publications/84862934325
UR - https://www.scopus.com/pages/publications/84862934325#tab=citedBy
U2 - 10.5588/ijtld.10.0795
DO - 10.5588/ijtld.10.0795
M3 - Article
C2 - 22236919
AN - SCOPUS:84862934325
SN - 1027-3719
VL - 16
SP - 192
EP - 195
JO - International Journal of Tuberculosis and Lung Disease
JF - International Journal of Tuberculosis and Lung Disease
IS - 2
ER -
